Zai Lab Ltd ($ZLAB)
Filing Information
| Accession Number | 0000905148-26-001542 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 3, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
74,643
Total Value
$202,064.90
P&L
+inf% (+$304,211.05)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Head of Global Oncology Research and Development | American Depositary Shares | โ | Apr 1, 2026 | Exercise/Conversion | 19,523 | โ | โ | 64,280 | Direct | โ | View Details | |
President, Head of Global Oncology Research and Development | American Depositary Shares | โ | Apr 2, 2026 | Exercise/Conversion | 5,391 | โ | โ | 69,671 | Direct | โ | View Details | |
President, Head of Global Oncology Research and Development | American Depositary Shares | โ | Apr 2, 2026 | Sale | 9,910 | $20.39 | $202,064.90 | 59,761 | Direct | โ | View Details | |
President, Head of Global Oncology Research and Development | Performance-Based Share Units | Derivative | Mar 4, 2026 | Grant/Award | 14,905 | $0.00 | $0.00 | 14,905 | Direct | โ | View Details | |
President, Head of Global Oncology Research and Development | Restricted Share Units | Derivative | Apr 1, 2026 | Exercise/Conversion | 19,523 | $0.00 | $0.00 | 39,046 | Direct | โ | View Details | |
President, Head of Global Oncology Research and Development | Restricted Share Units | Derivative | Apr 2, 2026 | Exercise/Conversion | 5,391 | $0.00 | $0.00 | 5,391 | Direct | โ | View Details |